Last viewed: CFRX


Prices are updated after-hours



nasdaq:CFRX ContraFect Corporation

CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-32.4% 1m) (-97.8% 1y) (0.0% 2d) (0.0% 3d) (0.7% 7d) (-42.52% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 2,826,272

http://www.contrafect.com
Sec Filling | Patents | 24 employees


(US) ContraFect Corp. is a clinical stage biotechnology company, which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.

antibody   monoclonal antibodies   infectious disease   influenza   treatment   bloodstream   injection  

add to watch list email alert is off

Press-releases


Methicillin-Resistant Staphylococcus aureus Infection Pipeline Clinical Trials Featuring 25+ companies
Published: 2023-01-25 (Crawled : 22:00) - biospace.com/
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: -14.38% H: 0.0% C: 0.0%

trials companies infection pipeline
ContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement
Published: 2022-12-13 (Crawled : 13:20) - globenewswire.com
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: -8.94% H: 0.0% C: 0.0%

offering direct
ContraFect Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections
Published: 2022-11-28 (Crawled : 14:00) - biospace.com/
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

for application infections trial approval
ContraFect Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-14 (Crawled : 13:00) - globenewswire.com
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: 7.22% H: 0.0% C: 0.0%

financial update results
ContraFect Announces Independent DSMB Recommends Exebacase Phase 3 DISRUPT Study Be Stopped for Futility Following Interim Analysis
Published: 2022-07-13 (Crawled : 21:00) - biospace.com/
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: -3.58% H: 10.41% C: 5.76%

for study phase 3
Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections
Published: 2022-06-14 (Crawled : 12:00) - globenewswire.com
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: 1.35% H: 7.99% C: -7.99%

conference infections potential
ContraFect to Present Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Combat MRSA at ASM Microbe 2022
Published: 2022-06-06 (Crawled : 12:20) - biospace.com/
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: 1.51% H: 2.08% C: -0.59%

potential
BioSpace Movers & Shakers: New Appointments for Maraganore, Afeyan
Published: 2022-05-27 (Crawled : 12:00) - biospace.com/
INDP | News | $1.734 3K twitter stocktwits trandingview |
Manufacturing
| | O: -1.11% H: 3.26% C: 1.54%
JNJ | News | $164.04 0.39% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 0.0% C: 0.0%
NKTR | $3.115 -1.11% 250K twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 4.0% C: 2.61%
PODD | $293.13 1.3% 37K twitter stocktwits trandingview |
Health Technology
| | O: 5.76% H: 2.5% C: 1.04%
HALO | News A | $51.295 -0.73% 80K twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 3.36% C: 3.27%
GLPG | $43.32 -0.18% 14K twitter stocktwits trandingview |
Health Technology
| | O: -0.83% H: 1.76% C: 1.76%
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: -1.18% H: 8.96% C: 8.51%
CLGN | $12.0 3.4K twitter stocktwits trandingview |
Health Technology
| | O: 2.07% H: 1.71% C: 1.71%
ASND | News | $116.63 0.24% 32K twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: -0.62%

for
ContraFect Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-05-20 (Crawled : 18:00) - biospace.com/
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: 1.86% H: 3.66% C: 1.93%

nasdaq grant
ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting
Published: 2022-04-18 (Crawled : 12:00) - globenewswire.com
CFRX | $0.0647 -3.86% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.76% H: 11.79% C: 9.74%

potential
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
54% 46%

Top 10 Gainers
DGLY | News | $5.34 1691.95% 72K twitter stocktwits trandingview |
Electronic Technology

CELZ | $1.08 108.78% 91M twitter stocktwits trandingview |

GFAI | $0.463 35.58% 43M twitter stocktwits trandingview |

BJDX | $0.619 32.66% 1.8M twitter stocktwits trandingview |

MSGM P 1 d | $16.63 26.18% 4.4M twitter stocktwits trandingview |

PRFX | $0.63 26.0% 12M twitter stocktwits trandingview |
Health Technology

NEWR A | $78.385 21.38% 2M twitter stocktwits trandingview |
Technology Services

THCH | $5.08 20.95% 310K twitter stocktwits trandingview |
n/a

BBLG | $0.3799 20.76% 640K twitter stocktwits trandingview |
n/a

KPRX | News | $5.42 19.12% 2.6M twitter stocktwits trandingview |
Manufacturing


Last 48 Hours Insiders Buying
TPL P 21 | $1908.9 -4.05% 6K twitter stocktwits trandingview |
Miscellaneous
| 15:50
CMPR P 8059 | $38.4 2.16% 31K twitter stocktwits trandingview |
Commercial Services
| 15:21
APLD P 25000 | $3.44 3.61% 450K twitter stocktwits trandingview |
Manufacturing
| 14:50
MSBI P 673 | $26.3 -0.19% 8.8K twitter stocktwits trandingview |
Finance
| 22:50
AKAM | News P 286 | $87.11 -1.19% 220K twitter stocktwits trandingview |
Technology Services
| 22:20
PFBX P 330 | $14.15 0 twitter stocktwits trandingview |
Finance and Insurance
| 16:30
CLFD P 3100 | $64.745 -0.07% 160K twitter stocktwits trandingview |
Electronic Technology
| 16:00
HPKEW 4 | $16.0 0% twitter stocktwits trandingview |
Industrial Services
| 23:50

12 months watchlist earnings calendar